Abstract
We have seen data on the natural history of Stage B prostate cancer, which address the degree of variability in tumor host interactions that confound our analyses of treatment outcome with what we call the “biology of the tumor”. Since the criteria of tumor innocence have not been developed, we continued to address all of our B1 and B2 lesions in approximately the same fashion. We have seen though the importance of supporting attempts to analyze and separate the so-called innocent tumors from those that are other than innocent.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Coffey, D.S. (1988). Panel Discussion: Management of Stages B1 and B2 Disease. In: Coffey, D.S., Resnick, M.I., Dorr, F.A., Karr, J.P. (eds) A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1667-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1667-1_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8925-8
Online ISBN: 978-1-4613-1667-1
eBook Packages: Springer Book Archive